GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (NAS:MBOT) » Definitions » Total Current Liabilities

Microbot Medical (Microbot Medical) Total Current Liabilities : $1.18 Mil (As of Mar. 2024)


View and export this data going back to 1992. Start your Free Trial

What is Microbot Medical Total Current Liabilities?

Total current liabilities includes Accounts Payable & Accrued Expense, Short-Term Debt & Capital Lease Obligation, Other Current Liabilities, and Current Deferred Liabilities. Microbot Medical's total current liabilities for the quarter that ended in Mar. 2024 was $1.18

Microbot Medical Total Current Liabilities Historical Data

The historical data trend for Microbot Medical's Total Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Microbot Medical Total Current Liabilities Chart

Microbot Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.83 1.35 1.98 2.07 3.79

Microbot Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.23 1.32 1.49 3.79 1.18

Microbot Medical Total Current Liabilities Calculation

Total Current Liabilities is the total amount of liabilities that the company needs to pay over the next 12 months.

Microbot Medical's Total Current Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=2.568+0.191
+Other Current Liabilities+Current Deferred Liabilities
=1.027+0
=3.79

Microbot Medical's Total Current Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Current Liabilities=Accounts Payable & Accrued Expense+Short-Term Debt & Capital Lease Obligation
=0.992+0.191
+Other Current Liabilities+Current Deferred Liabilities
=0+0
=1.18

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The increase of Total Current Liabilities of a company is not necessarily a bad thing. This may conserve the company's cash and contribute positively to cash flow.

Total Current Liabilities is linked to Total Current Assets through the Current Ratio and Working Capital. The Current Ratio is equal to dividing total current assets by total current liabilities. It is frequently used as an indicator of a company's liquidity, its ability to meet short-term obligations. Net working capital is calculated as Total Current Assets minus Total Current Liabilities.

Be Aware

Stay away from companies that roll over the debt e.g. Bear Stearns

When investing in financial institutions, Buffett shies from those who are bigger borrowers of short term than long term debt.

His favorite Wells Fargo has 57 cents short term debt for every dollar of long term.

Aggressive banks (like Bank of America) has $2.09 short term for every dollar long term

Microbot Medical Total Current Liabilities Related Terms

Thank you for viewing the detailed overview of Microbot Medical's Total Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Microbot Medical (Microbot Medical) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Microbot Medical Inc (NAS:MBOT) » Definitions » Total Current Liabilities
Comparable Companies
NXGL IMTH MHUA LUCY GCTK CBSC EKSO POAI NEPH ECIA ISRG XPAR:EL BDX XSWX:ALC TSE:7741 RMD OCSE:COLO B TSE:4543 WST XSWX:STMN
Traded in Other Exchanges
CY9D:Germany
Address
25 Recreation Park Drive, Unit 108, Hingham, MA, USA, 02043
Website
https://microbotmedical.com
Microbot Medical Inc is a pre-clinical medical device company. It specializes in developing next-generation micro-robotic medical technologies that can change the future of medicine. Their vision is to improve the quality of life of millions of patients globally by advancing micro-robotic technologies to perform surgical procedures and offer physicians and their patients less invasive and more precise solutions. The company's innovative platforms LIBERTY and Self-Cleaning Shunt (SCS) are in one of the fastest-growing segments in healthcare. The group continuously develops its technology with the goal to improve surgical outcomes worldwide. The firm presently holds domestic and global patents that strengthen its product portfolio and create barriers of entry.
Executives
Rachel Vaknin officer: Chief Financial Officer DROR 3/10, ZICHRON YAAKOV L3 3090216
Simon Sharon officer: General Manager & CTO 8 HAMADA STREET, ZICHRON YAACOV L3 3090708
Yoseph Bornstein director, 10 percent owner 16 IRUS STREET, ROSH HA'AYIN L3 4858022
Tal Baruch Wenderow director 1149, BEACON STREET, NEWTON MA 02461
Eyal Morag officer: Chief Medical Officer BONEY HAEAR 3 STREET, APT #13, TEL AVIV L3 6937303
Aileen Ptucha Stockburger director 26 WELLINGTON CT, BELLE MEADE NJ 08502
Harel Gadot director, 10 percent owner, officer: Chairman and CEO 5 VILLAGE LANE, HINGHAM MA 02043
Joseph Mona 10 percent owner 808 HAMPTON ST, COLUMBIA SC 29201
Prattipati Laxminarain director 3 HEWINS FARM ROAD, WELLESLEY MA 02481
Yoav Zvi Waizer director 8 HAVERED STREET, RAANANA L3 4352308
Moshe Shoham director 22 BEDOLACH STREET, HOSHAYA L3 1791500
Leon Lewkowicz 10 percent owner GORDON STREET 10, APARTMENT 7, TEL-AVIV L3 63458
Martin J. Madden director C/O MICROBOT MEDICAL INC., 175 DERBY STREET 27/1, HINGHAM MA 02043
Yehezkel Himelfarb officer: General Manager & COO 32 BEN YOSEF STREET, TEL-AVIV L3 6912530
Sandra Berkson 10 percent owner C/O SABER HOLDING GMBH, WEIN KRUMMBAUMGASSE C4 1020

Microbot Medical (Microbot Medical) Headlines

From GuruFocus

Microbot Medical Announces $2 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules

By Marketwired • 06-27-2023

Microbot Medical Announces Closing of $1.4 Million Registered Direct Offering of Common Stock Priced At-The-Market under Nasdaq Rules

By sperokesalga sperokesalga • 05-23-2023

LIBERTY Robotic Surgical System Achieved Additional Milestone in its Path to First in Human and Regulatory Process

By sperokesalga sperokesalga • 05-31-2023

Microbot Medical Expands its Physician Support with the Addition of Leading Italian Interventional Radiologist Irene Bargellini, M.D., to its Scientific Advisory Board

By Marketwired • 07-11-2023

Microbot Medical Expand IP protection in Japan

By Marketwired • 06-22-2023

Microbot Medical Received Confirmation for the Commencement of Its CE Mark Approval Process During the First Half of 2024

By Marketwired • 10-24-2023

Microbot Medical Gains Global Recognition; Professor Vincent Vidal to Present an Abstract on The LIBERTY� Robotic Surgical System at CIRSE 2023

By Marketwired • 09-08-2023

Gerry O'Sullivan, the Latest Member to Join Microbot Medical's Scientific Advisory Board, to Leverage Extensive Interventional Radiology Experience to Progress the LIBERTY� Robotic System Through Regulatory, Clinical and Commercialization Phases

By sperokesalga sperokesalga • 03-23-2023

Microbot Medical Announces Grant of Summary Judgment in its Favor and Dismissal of Counterclaim Against Company

By Marketwired • 10-19-2023

Microbot Medical Boosts Manufacturing and Commercialization Capabilities for its Robotic Surgical System

By Marketwired • 08-15-2023